Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03001570
Title Accelerated Modulated Fractionation (SIB-IMRT) for Head and Neck District (FAMOSO)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Institute of Oncology
Indications

oropharynx cancer

laryngeal squamous cell carcinoma

hypopharynx cancer

Therapies

Cetuximab + Radiotherapy

Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.